Professor David Spiegelhalter

Publications

COVID-19 risk perception: A longitudinal analysis of its predictors and associations with health protective behaviours in the United Kingdom

CR Schneider, S Dryhurst, J Kerr, ALJ Freeman, G Recchia, D Spiegelhalter, S van der Linden

– Journal of Risk Research

(2021)

(DOI: 10.1080/13669877.2021.1890637)

The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis.

C Jackson, ALJ Freeman, Z Szlamka, DJ Spiegelhalter

– PloS one

(2021)

16,

e0246441

(DOI: 10.1371/journal.pone.0246441)

Five rules for evidence communication

M Blastland, ALJ Freeman, S van der Linden, TM Marteau, D Spiegelhalter

– Nature

(2020)

587,

362

(DOI: 10.1038/d41586-020-03189-1)

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study

AK Clift, CAC Coupland, RH Keogh, K Diaz-Ordaz, E Williamson, EM Harrison, A Hayward, H Hemingway, P Horby, N Mehta, J Benger, K Khunti, D Spiegelhalter, A Sheikh, J Valabhji, RA Lyons, J Robson, MG Semple, F Kee, P Johnson, S Jebb, T Williams, J Hippisley-Cox

– The BMJ

(2020)

371,

m3731

(DOI: 10.1136/bmj.m3731)

Communicating personalised risks from COVID-19: guidelines from an empirical study

A Freeman, J Kerr, G Recchia, C Schneider, ACE Lawrence, L Finikarides, G Luoni, S Dryhurst, D Spiegelhalter

(2020)

(DOI: 10.1101/2020.10.05.20206961)

Use of "normal" risk to improve understanding of dangers of covid-19

D Spiegelhalter

– The BMJ